President Donald Trump announced a deal with Regeneron, a drug manufacturer and biotechnology company, to reduce the cost of its pharmaceutical products, marking a key milestone in the administration’s flagship drug-pricing initiative.
Trump announces deal with Regeneron Pharmaceuticals, reducing drug prices
Jenna Lee
Apr 23, 2026 | 8:54 PM
We use cookies for various purposes including analytics and marketing. By continuing to use this service, you agree to use cookies by us and our third-party service providers as described in the Privacy Policy.